FDA: Apotex hasn't corrected 'serious' manufacturing violations

FDA warned Apotex again of "serious and repeat" manufacturing violations at two of its plants, saying that the generics maker hasn't done enough to correct problems raised in previous agency warnings. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.